✦ LIBER ✦

Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa

✍ Scribed by William C. Mobley; Stefan A. Loening; Ambati S. Narayana; David A. Culp

Book ID: 119045774
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 574 KB
Volume: 27
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(86)90309-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UP-03.35: Comparison of the different in

UP-03.35: Comparison of the different intravesical chemotherapy agents effects (mitomycin-C, thiotepa, mitomycin-C+thiotepa, BCG) on superficial transitional cell carcinoma of the bladder after TURBT (over 5 years of experience)

✍ A. Yarmohamadi; S. Yarmohamadi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Intravesical mitomycin C combined with h

Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder

✍ Sarel Halachmi; Boaz Moskovitz; Massimo Maffezzini; Giario Conti; Fabrizio Verwe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 444 KB

Single Dose Intravesical Thiotepa as an

Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder Carcinoma

✍ K. G. BURNAND; P. J. R. BOYD; M. E. MAYO; K. E. D. SHUTTLEWORTH; R. W. LLOYD-DAV 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

Efficacy of intravesical mitomycin C in

Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder

✍ Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Haim Alon; Dr. Yoav Horn 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 1 views

We treated 47 patients with recurrent transitional cell carcinoma of the bladder with intravesical chemotherapy. Twenty milligrams of mitomycin C per treatment was introduced 7 days after transurethral resection (TUR) or diagnostic cystoscopy, and was repeated at 2-week intervals for five times foll

Phase I Clinical Trial and Pharmacokinet

Phase I Clinical Trial and Pharmacokinetics of Intravesical Mitomycin C in Dogs with Localized Transitional Cell Carcinoma of the Urinary Bladder

✍ A.H. Abbo; D.R. Jones; A.R. Masters; J.C. Stewart; L. Fourez; D.W. Knapp 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Long-term follow-up of patients with sup

Long-term follow-up of patients with superficial transitional cell carcinoma of the urinary bladder treated by intravesical mitomycin C

✍ Abraham Pavlotsky; Abraham Eidelman; Frida Barak; Natalio Walach; Dr. Yoav Horn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views